BCHE and Alzheimer disease: Data from the ICTUS study accessed the effects of Gingko biloba supplementation in mild-to-moderate Alzheimer’s disease patients receiving cholinesterase inhibitors, some added cognitive benefits measured by MMSE rather than ADAS-cog was observed at 12 months but not at 6 months [26].